A new cross-trait genetic analysis published in Arthritis Research & Therapy has identified a significant genetic correlation between osteoarthritis and fibromyalgia. The study, led by Lin-Hong Shi and colleagues, utilized large-scale genome-wide association study summary data to investigate whether the epidemiological association between these two conditions reflects a shared genetic architecture. The researchers found a significantly greater genetic correlation between these two traits.
The study employed a multi-faceted statistical approach to dissect the relationship between osteoarthritis and fibromyalgia. The team utilized Linkage disequilibrium score regression analysis and Multimarker Analysis of GenoMic Annotation to assess the genetic overlap. These methods were complemented by fine-mapping and co-localization analysis to pinpoint specific genomic regions and variants. Functional enrichment analyses were also conducted to determine which biological pathways were significantly represented among the shared genetic factors.
The results revealed 17 significant single nucleotide polymorphisms shared between osteoarthritis and fibromyalgia, including two novel SNPs. Bayesian linear regression confirmed that these shared SNPs exert an effect on the joint osteoarthritis-fibromyalgia phenotype. Fine-mapping highlighted a specific variant with a high causal probability for osteoarthritis, implicating a shared genetic hub.
Functional enrichment analysis indicated that the identified genes and gene sets significantly converged on the ferroptosis pathway for the joint osteoarthritis-fibromyalgia phenotype.
To explore potential therapeutic implications, the researchers performed molecular docking analyses to investigate intermolecular interactions between potential target drugs and overlapping core target proteins. The analysis verified strong binding affinity between the overlapping core target protein and Coenzyme Q10, also known as CoQ10, as well as vitamin E. These findings suggest that compounds targeting the ferroptosis pathway may have beneficial effects on the joint osteoarthritis-fibromyalgia phenotype.
The study also highlighted the gene SLC39A8 as a potential marker for shared genetic architecture. The authors suggested that osteoarthritis patients with variants in SLC39A8 might benefit from early screening for fibromyalgia or arthritis pain due to central sensitization. This recommendation is based on the shared genetic basis identified in the study, which may predispose individuals to both conditions.
The research was published as an open access article in Arthritis Research & Therapy. The study was conducted by a team of researchers including Lin-Hong Shi, M. Tuncay Duruöz, Dongquan Shi, Changhai Ding, and David J. Hunter. The article is citable and carries a permanent DOI.
Subject of Research: Genetic correlation between osteoarthritis and fibromyalgia
Article Title: Cross-trait genetic analysis of osteoarthritis and fibromyalgia implicates ferroptosis and potential therapeutic targets
Article References: Shi, L.-H., Duruöz, M. T., Shi, D., Ding, C., & Hunter, D. J. (2026). Cross-trait genetic analysis of osteoarthritis and fibromyalgia implicates ferroptosis and potential therapeutic targets. Arthritis Research & Therapy. https://doi.org/10.1186/s13075-026-03891-x
Image Credits: AI Generated
DOI: 10.1186/s13075-026-03891-x
Keywords: osteoarthritis, fibromyalgia, genetic correlation, ferroptosis, GWAS, CoQ10, vitamin E, SLC39A8, molecular docking, Arthritis Research & Therapy, Cross-trait, genetic
News Source: Juliet Wilcox. (November 9, 2026). Genetic Link Between Osteoarthritis and Fibromyalgia Identified. Scienmag.



